A framework for the present and future development of experimental models of female sexual dysfunction

Taben Hale, J. P W Heaton, M. A. Adams

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Female sexual dysfunction (FSD) is currently categorized according to disorders of (i) desire, (ii) arousal, (iii) orgasm and (iv) sexual pain. The advancement of research defining the physiological, pathophysiological and psychological mechanisms of these disorders, and to develop treatments for FSD, has been hampered by the paucity of experimental paradigms and animal models. It may be that animal models of FSD are best suited to address arousal disorders that include persistent or routine inability to attain or maintain genital lubrication or engorgement. Although still limited in scope, experimental models of FSD have involved a range of in vitro to in vivo methodologies. Specifically, the in vitro and in situ models include vaginal or clitoral smooth muscle preparations, histological evaluation and vaginal blood flow assessments. Previously, in vivo studies of sexual responses focussed on behavioral paradigms involving lordotic posturing and receptivity, as well as indices of motivation using a dual chamber pacing method. Recently, a new model of female sexual arousal was developed using pharmacological CNS stimulation; responses that were found to be sensitive to cardiovascular status, aging and hormonal conditions. It is important that a wide variety of animal models continue to be developed to reflect the multifactorial basis of the condition.

Original languageEnglish (US)
JournalInternational Journal of Impotence Research
Volume15
Issue numberSUPPL. 5
DOIs
StatePublished - Oct 2003
Externally publishedYes

Fingerprint

Theoretical Models
Arousal
Animal Models
Orgasm
Lubrication
Smooth Muscle
Motivation
Pharmacology
Psychology
Pain
Research
In Vitro Techniques
Therapeutics

Keywords

  • Animal models
  • Behavioral models
  • Female sexual dysfunction
  • Pharmacological models
  • Physiological models

ASJC Scopus subject areas

  • Urology

Cite this

A framework for the present and future development of experimental models of female sexual dysfunction. / Hale, Taben; Heaton, J. P W; Adams, M. A.

In: International Journal of Impotence Research, Vol. 15, No. SUPPL. 5, 10.2003.

Research output: Contribution to journalArticle

@article{c3c41813d0b84461ba92f3b4b65a8aa7,
title = "A framework for the present and future development of experimental models of female sexual dysfunction",
abstract = "Female sexual dysfunction (FSD) is currently categorized according to disorders of (i) desire, (ii) arousal, (iii) orgasm and (iv) sexual pain. The advancement of research defining the physiological, pathophysiological and psychological mechanisms of these disorders, and to develop treatments for FSD, has been hampered by the paucity of experimental paradigms and animal models. It may be that animal models of FSD are best suited to address arousal disorders that include persistent or routine inability to attain or maintain genital lubrication or engorgement. Although still limited in scope, experimental models of FSD have involved a range of in vitro to in vivo methodologies. Specifically, the in vitro and in situ models include vaginal or clitoral smooth muscle preparations, histological evaluation and vaginal blood flow assessments. Previously, in vivo studies of sexual responses focussed on behavioral paradigms involving lordotic posturing and receptivity, as well as indices of motivation using a dual chamber pacing method. Recently, a new model of female sexual arousal was developed using pharmacological CNS stimulation; responses that were found to be sensitive to cardiovascular status, aging and hormonal conditions. It is important that a wide variety of animal models continue to be developed to reflect the multifactorial basis of the condition.",
keywords = "Animal models, Behavioral models, Female sexual dysfunction, Pharmacological models, Physiological models",
author = "Taben Hale and Heaton, {J. P W} and Adams, {M. A.}",
year = "2003",
month = "10",
doi = "10.1038/sj.ijir.3901076",
language = "English (US)",
volume = "15",
journal = "International Journal of Impotence Research",
issn = "0955-9930",
publisher = "Nature Publishing Group",
number = "SUPPL. 5",

}

TY - JOUR

T1 - A framework for the present and future development of experimental models of female sexual dysfunction

AU - Hale, Taben

AU - Heaton, J. P W

AU - Adams, M. A.

PY - 2003/10

Y1 - 2003/10

N2 - Female sexual dysfunction (FSD) is currently categorized according to disorders of (i) desire, (ii) arousal, (iii) orgasm and (iv) sexual pain. The advancement of research defining the physiological, pathophysiological and psychological mechanisms of these disorders, and to develop treatments for FSD, has been hampered by the paucity of experimental paradigms and animal models. It may be that animal models of FSD are best suited to address arousal disorders that include persistent or routine inability to attain or maintain genital lubrication or engorgement. Although still limited in scope, experimental models of FSD have involved a range of in vitro to in vivo methodologies. Specifically, the in vitro and in situ models include vaginal or clitoral smooth muscle preparations, histological evaluation and vaginal blood flow assessments. Previously, in vivo studies of sexual responses focussed on behavioral paradigms involving lordotic posturing and receptivity, as well as indices of motivation using a dual chamber pacing method. Recently, a new model of female sexual arousal was developed using pharmacological CNS stimulation; responses that were found to be sensitive to cardiovascular status, aging and hormonal conditions. It is important that a wide variety of animal models continue to be developed to reflect the multifactorial basis of the condition.

AB - Female sexual dysfunction (FSD) is currently categorized according to disorders of (i) desire, (ii) arousal, (iii) orgasm and (iv) sexual pain. The advancement of research defining the physiological, pathophysiological and psychological mechanisms of these disorders, and to develop treatments for FSD, has been hampered by the paucity of experimental paradigms and animal models. It may be that animal models of FSD are best suited to address arousal disorders that include persistent or routine inability to attain or maintain genital lubrication or engorgement. Although still limited in scope, experimental models of FSD have involved a range of in vitro to in vivo methodologies. Specifically, the in vitro and in situ models include vaginal or clitoral smooth muscle preparations, histological evaluation and vaginal blood flow assessments. Previously, in vivo studies of sexual responses focussed on behavioral paradigms involving lordotic posturing and receptivity, as well as indices of motivation using a dual chamber pacing method. Recently, a new model of female sexual arousal was developed using pharmacological CNS stimulation; responses that were found to be sensitive to cardiovascular status, aging and hormonal conditions. It is important that a wide variety of animal models continue to be developed to reflect the multifactorial basis of the condition.

KW - Animal models

KW - Behavioral models

KW - Female sexual dysfunction

KW - Pharmacological models

KW - Physiological models

UR - http://www.scopus.com/inward/record.url?scp=0142246424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142246424&partnerID=8YFLogxK

U2 - 10.1038/sj.ijir.3901076

DO - 10.1038/sj.ijir.3901076

M3 - Article

C2 - 14551581

AN - SCOPUS:0142246424

VL - 15

JO - International Journal of Impotence Research

JF - International Journal of Impotence Research

SN - 0955-9930

IS - SUPPL. 5

ER -